Key facts
| Price (PPV) | 43.80 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | carvédilol |
| Class | Beta blocking agents |
| ATC code | C07AG02 |
| Manufacturer | PHARMIS |
| Presentation | Boite de 30 |
| Nature | Médicament |
| Hospital price | 27.40 MAD |
| Data collected on | 9/8/2026 |
Indications
Hypertension artérielle essentielle (légère à modérée) ainsi que prévention des crises en cas d'angor chronique. Traitement de l'insuffisance cardiaque stable légère à sévère (classes II à IV de la NYHA) d'origine ischémique ou cardiomyopathique, en plus du traitement standard (diurétiques, digoxine, inhibiteurs de l'ECA).
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Cardix 6.25 mg (PHI) contains the same active substance as Celeno 6.25 mg (Carvédilol) at the same strength, but in a different pack: Boîte de 28 at 41.90 MAD, i.e. 1.50 MAD per unit against 1.46 MAD for Celeno 6.25 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Cardinor 6.25 mg | COOPER PHARMA | Boîte de 30 | 43.80 MAD | 1.46 / unit | — |
| Coronat 6.25 mg | ATLAS PHARM | Boîte de 30 | 43.80 MAD | 1.46 / unit | — |
| Xedilol 6.25 mg | SOTHEMA | Boîte de 30 | 43.80 MAD | 1.46 / unit | — |
| Dilatrend 6.25 mg | BOTTU S.A. | Boîte de 30 | 71.10 MAD | 2.37 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Cardix 6.25 mg | PHI | Boîte de 28 | 41.90 MAD | 1.50 / unit |
| Cardinor 6.25 mg | COOPER PHARMA | Boîte de 60 | 85.70 MAD | 1.43 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Celeno 6.25 mg
Celeno 6.25 mg belongs to the beta blocking agents therapeutic class. In Morocco, this drug is marketed by PHARMIS and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Celeno 6.25 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Celeno 6.25 mg
Answers to common questions from Moroccan patients about this drug.